Mar 8 |
Voyager Therapeutics: A Tortoise With A Shot At Making Gene Therapy Deliver Easier
|
Mar 4 |
Analysts Just Made A Major Revision To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Revenue Forecasts
|
Feb 29 |
Q4 2023 Voyager Therapeutics Inc Earnings Call
|
Feb 29 |
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Voyager Therapeutics, Inc. (VYGR) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Voyager Therapeutics Inc (VYGR) Announces Strong Year-End Financials with Significant Cash Position
|
Feb 28 |
Voyager Therapeutics GAAP EPS of $1.25 beats by $1.54, revenue of $90.06M beats by $69.42M
|
Feb 28 |
Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
|
Feb 28 |
Earnings Scheduled For February 28, 2024
|
Feb 27 |
Voyager Therapeutics Q4 2023 Earnings Preview
|